Behavioral medicine approaches to somatoform disorders

Journal of Consulting and Clinical Psychology

Volumn 70, Issue 3, 2002, Pages 810-827

  Looper, Karl J ^a,b   Kirmayer, Laurence J ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE EXTRACT; PLACEBO;

ARTICLE; BEHAVIOR THERAPY; BEHAVIORAL MEDICINE; BODY DYSMORPHIC DISORDER; CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISTRESS SYNDROME; HEALTH CARE COST; HUMAN; HYPOCHONDRIASIS; MAJOR CLINICAL STUDY; MENTAL DISEASE; NEUROSIS; RANDOMIZED CONTROLLED TRIAL; THORAX PAIN; TREATMENT OUTCOME; TREATMENT PLANNING;

BEHAVIORAL MEDICINE; HUMANS; SOMATOFORM DISORDERS;

EID: 0036279134     PISSN: 0022006X     EISSN: None     Source Type: Journal    
DOI: 10.1037/0022-006X.70.3.810     Document Type: Article

References (151)

1. The meaning of psychological symptoms: Effectiveness of a group intervention with hypochondriacal patients
2. Somatization and medicalization in the era of managed care
3. Functional somatic syndromes
4. Hypochondriacal patients' beliefs about good health
5. A cognitive-educational treatment for hypochondriasis
6. The amplification of somatic symptoms
7. Transient hypochondriasis
8. The management of chronic somatisation
9. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use
10. Cognitive and behavioural treatment of hypochondriasis
11. Assessment of psychological status using interviews and self-report instruments
12. Overview of adult health measures fielded in Rand's health insurance study
13. Cognitive behaviour therapy in chronic fatigue syndrome
14. Cognitive-behavioral treatment of women's body-image dissatisfaction
15. The great American shape-up: Body image survey report
16. Defining empirically supported therapies
17. Two psychological treatments for hypochondriasis
18. The development and validation of the Body Shape Questionnaire
19. Journal of Neurology
20. Dimensions of hypochondriasis and the five-factor model of personality
21. Cognitive behavior therapy for chronic fatigue syndrome: A randomized controlled trial
22. Successful rehabilitation in conversion paralysis
23. Brief therapy of conversion reactions: An in-hospital technique
24. Comparison of interventions for women experiencing body image problems
25. Consultation-liaison service in the general hospital: Effects of cognitive-behavioral therapy in patients with physical nonspecific symptoms
26. Pharmacological treatment of somatization/hypochondriasis
27. Somatization in the community
28. DSM-IV hypochondriasis in primary care
29. Explanatory therapy in hypochondriasis
30. The utility of electromyographic biofeedback in the treatment of conversion paralysis
31. Conversion symptoms in a general hospital
32. A comparison of cognitive behavioral treatment for chronic fatigue syndrome and primary depression
33. The chronic fatigue syndrome: A comprehensive approach to its definition and study
34. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome
35. Three forms of somatization presenting in primary care settings in Spain
36. Prognosis and differential diagnosis of conversion reactions (a follow-up study)
37. Perceptual and cognitive abnormality model of hypochondriasis: Amplification and physiological reactivity in women
38. Cognitive-behavioral body image therapy: Comparative efficacy of group and modest-contact treatment
39. Investigation of the Karnofsky performance status as a measure of quality of life
40. Pseudoseizures, families, and unspeakable dilemmas
41. Somatization in cross-cultural perspective: A World Health Organization study in primary care
42. The syndrome of hypochondriasis: A cross-national study in primary care
43. Hypochondriacs' estimation of negative outcomes: Domain-specificity and responsiveness to reassuring and alarming information
44. Hysterical conversion: A prognostic study
45. Arousal and perceptual sensitivity in hypochondriacs
46. The socialization of introspection and illness behavior
47. A study of the effectiveness of two group behavioral medicine interventions for patients with psychosomatic complaints
48. Further evidence for a broader concept of somatization disorder using the somatic symptom index
49. Interpretation of bodily symptoms in hypochondriasis
50. Clomipramine vs. desipramine crossover trial in body dysmorphic disorder
51. Narcosuggestion in chronic conversion symptoms using combined intravenous amobarbital and methylphenidate
52. Progress and symptoms one year after discharge from the emergency department in patients with acute chest pain
53. The use of the nitrogen mustards in the palliative treatment of carcinoma
54. Enhancing the health of somatization disorder patients: Effectiveness of short-term group therapy
55. Somatization: A spectrum of severity
56. Distressed high utilizers of medical care: DSM-III-R diagnoses and treatment needs
57. Medically unexplained symptoms in primary care
58. Prevalence of chronic fatigue syndrome in a community population in Japan
59. Psychotherapeutic strategies in hypochondriasis: A clinical study
60. Prognosis of treated hypochondriasis: A clinical study
61. The relief of distress following attendance at a clinic
62. Course and outcome of conversion and somatization disorders, a four-year follow-up
63. Mind and body as metaphors: Hidden values in biomedicine
64. Improvisation and authority in illness meaning
65. Rhetorics of the body: Medically unexplained symptoms in sociocultural perspective
66. Broken narratives: Clinical encounters and the poetics of illness experience
67. Hypochondriasis in primary care
68. Three forms of somatization in primary care: Prevalence, co-occurrence, and sociodemographic characteristics
69. Somatoform disorders
70. Culture and somatization: Clinical, epidemiological, and ethnographic perspectives
71. Psychological treatment for atypical non-cardiac chest pain: A controlled evaluation
72. Symptoms in the community, prevalence, classification, and psychiatric comorbidity
73. The survival of hysteria
74. Group therapy for somatization disorders in general practice: Effectiveness of a short cognitive-behavioural treatment model
75. Therapeutic and anti-therapeutic consequences of workers' compensation
76. Structural factor analyses for medically unexplained somatic symptoms of somatization disorder in the Epidemiologic Catchment Area Study
77. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: A double-blind, placebo-controlled trial
78. The economic impact of chronic fatigue syndrome
79. Hypochondriacal concerns in a community population
80. Attributions about common bodily sensations: Their associations with hypochondriasis and anxiety
81. Referrals to a cardiac clinic for chest pain or palpitations
82. A controlled trial of cognitive behavioural therapy for noncardiac chest pain
83. Medical family therapy with somatizing patients: The co-creation of therapeutic stories
84. Two-year follow-up of behavioral treatment and maintenance for body dysmorphic disorder
85. Treatment of somatization in primary care
86. The inpatient treatment of patients suffering from (motor) conversion symptoms: A description of eight cases
87. Fluvoxamine for somatoform disorders: An open trial
88. Hypnosis and suggestion in the treatment of hysteria
89. The relevance of early parental experiences to adult dependency, hypochondriasis and utilization of primary physicians
90. Population based study of fatigue and psychological distress
91. Medically unexplained physical symptoms in primary care: A comparison of self-report screening questionnaires and clinical opinion
92. Efficacy and safety of fluvoxamine in body dysmorphic disorder
93. Insight, overvalued ideation, and delusional thinking in body dysmorphic disorder: Theoretical and treatment implications
94. Body dysmorphic disorder: 30 Cases of imagined ugliness
95. Group psychological treatment for chest pain with normal coronary arteries
96. Estimating the prevalence of chronic fatigue syndrome and associated symptoms in the community
97. One hundred cases of hysteria in eastern Libya
98. Attributions of common somatic symptoms
99. Transient and persistent hypochondriacal worry in primary care
100. The prognosis of hysteria/somatization disorder
101. Cognitive behavior therapy with and without size perception training for women with body image disturbance
102. Development of the Body Dysmorphic Disorder Examination
103. Cognitive-behavioral body image therapy for body dysmorphic disorder
104. Cognitive behavior therapy for negative body image
105. Effectiveness of psychiatric intervention with somatization disorder patients: Improved outcomes at reduced costs
106. Causal attributions about common somatic sensations among frequent general practice attenders
107. Cognitive behaviour therapy for the chronic fatigue syndrome: A randomised controlled trial
108. Management of conversion disorder
109. Somatic symptoms of distress: An international primary care study
110. Stability of somatization disorder and somatization symptoms among primary care patients
111. Consultation-liaison psychiatrists' management of somatoform disorders
112. The course of somatization and its effects on utilization of health care resources
113. Psychiatric consultation in somatization disorder: A randomized controlled study
114. A trial of the effect of a standardized psychiatric consultation on health outcomes and costs in somatizing patients
115. Cognitive behavioural therapy for medically unexplained physical symptoms: A randomised controlled trial
116. Behavioral management of conversion disorder: Retrospective study
117. Reassurance and treatment of hypochondriasis
118. Hysterical neurosis, conversion type: Clinical and epidemiological considerations
119. Lorazepam in the treatment of acute conversion disorder
120. The MOS Short-Form General Health Survey: Reliability and validity in a patient population
121. The amytal interview in the treatment of conversion disorder: Three case reports
122. Randomized controlled trial of cognitive behaviour therapy for repeated consultations for medically unexplained complaints: A feasibility study in Sri Lanka
123. Somatization disorder in a community population
124. Strategic-behavioral intervention in the treatment of chronic nonorganic motor disorders
125. Somatization and conversion disorders: Comorbidity and demographics at presentation
126. An approach to the treatment of abnormal ambulation resulting from conversion reaction
127. Cognitive-behavioral therapy for noncardiac chest pain: A randomized trial
128. Body dysmorphic disorder, a survey of fifty cases
129. Body dysmorphic disorder: A cognitive behavioural model and pilot randomised controlled trial
130. The treatment of hypochondriasis; Exposure plus response prevention vs cognitive therapy
131. A controlled trial of cognitive-behavioural treatment of hypochondriasis
132. The frequency and identification of false positive conversion reactions
133. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome
134. Psychiatric disorders in a U.S. urban community: 1975-1976
135. Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue and chronic fatigue syndrome: A prospective study in the primary care setting
136. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: A prospective primary care study
137. Functional somatic syndromes: One or many?
138. Briquet's syndrome (hysteria) is both a somatoform and a "psychoform" illness: A Minnesota Multiphasic Personality Inventory study
139. Psychiatric aspects of chest pain in the emergency department